may, 2017

04mayallday05alldayFeaturedImmuno-Oncology Breakthrough Summit


Event Details

Clinical to Commercial — Strategies and Innovative Trial Approaches to Gain Accelerated Approval and Commercialize Combination Therapies

May 4-5, 2017 • Courtyard Boston • Cambridge, MA

CBI’s Immuno-Oncology Breakthrough Summit provides pharmaceutical and biotech companies the knowledge and resources necessary to successfully bring immuno-oncology products from a clinical to commercial stage. This conference addresses key challenges faced throughout the drug life cycle and provides updates from regulatory bodies and economic perspectives to navigate this rapidly evolving landscape.


  • Assess the state of the industry by discussing abstracts and considering strategies implemented by successful organizations
  • Build and manage partnerships from R&D through commercial stages of the immunotherapy life cycle
  • Bridge the gap between clinical development and commercialization planning from Phase II to Phase III
  • Discover best practices when designing clinical trials to obtain approvals and reimbursement
  • Discuss challenges of combination therapies and their complexities
  • Justify price of product to maximize market access
  • Develop a unique product identity to differentiate and demonstrate key benefits in order to gain coverage by payers
  • Gain strategies to overcome major challenges to achieve market access


may 4 (Thursday) - 5 (Friday)


Courtyard Boston Cambridge

777 Memorial Drive Cambridge, MA 02139